Key result
Heterozygous MT1-MMP deficiency improves survival and preserves myocardial function versus wild-type in mice post-MI.
Why the study?
Does MT1-MMP deficiency improve survival and myocardial function following myocardial infarction in a mouse model?
Does MT1-MMP deficiency improve survival and myocardial function following myocardial infarction in a mouse model?
MT1-MMP is identified as the dominant collagenase responsible for postinfarction cardiac extracellular matrix remodeling and subsequent cardiac dysfunction, highlighting it as a potential therapeutic target.
Answers are grounded in this paper and cite their sources.
MT1-MMP inhibition merits further preclinical testing post-MI; leaves open translation to human outcomes.
The myocardial extracellular matrix (ECM), an interwoven meshwork of proteins, glycoproteins, proteoglycans, and glycosaminoglycans that is dominated by polymeric fibrils of type I collagen, serves as the mechanical scaffold on which myocytes are arrayed for coordinated and synergistic force transduction. Following ischemic injury, cardiac ECM remodeling is initiated via localized proteolysis, the bulk of which has been assigned to matrix metalloproteinase (MMP) family members. Nevertheless, the key effector(s) of myocardial type I collagenolysis both in vitro and in vivo have remained unidentified. In this study, using cardiac explants from mice deficient in each of the major type I collagenolytic MMPs, including MMP-13, MMP-8, MMP-2, MMP-9, or MT1-MMP, we identify the membrane-anchored MMP, MT1-MMP, as the dominant collagenase that is operative within myocardial tissues in vitro. Extending these observations to an in vivo setting, mice heterozygous for an MT1-MMP-null allele display a distinct survival advantage and retain myocardial function relative to wild-type littermates in an experimental model of myocardial infarction, effects associated with preservation of the myocardial type I collagen network as a consequence of the decreased collagenolytic potential of cardiac fibroblasts. This study identifies MT1-MMP as a key MMP responsible for effecting postinfarction cardiac ECM remodeling and cardiac dysfunction.
No takes yet. Share an insight, caveat, or question.
Koenig et al. (2012) studied Myocardial Infarction. MT1-MMP-null allele heterozygosity vs. Wild-type littermates was evaluated on Survival and myocardial function. Mice heterozygous for an MT1-MMP-null allele displayed a survival advantage and retained myocardial function relative to wild-type littermates following experimental myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: